Search Press releases Keywords From To 18 Feb 2022 Disposal of own shares Read More 11 Feb 2022 Disposal of own shares Read More 4 Feb 2022 Disposals of own shares Read More 4 Feb 2022 UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results Read More 2 Feb 2022 Transparency notification FMR LLC. Read More 2 Feb 2022 UCB Receives Positive CHMP Opinion Recommending Approval of BRIVIACT[®] (brivaracetam) and VIMPAT[®] (lacosamide) in the EU for Partial-Onset Seizures in Pediatric Patients From Two to Four Years Read More Pagination First page Previous page Previous … Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Page 32 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
